首页|肺部感染患者多重耐药菌的耐药性研讨

肺部感染患者多重耐药菌的耐药性研讨

扫码查看
目的 探究肺部感染患者多重耐药菌(MDR)的耐药性.方法 选取50例肺部感染患者,取患者痰液样本进行致病菌培养及药敏试验.分析肺部感染多重耐药菌构成情况、革兰阴性菌的耐药情况及革兰阳性菌的耐药情况.结果 50例肺部感染患者的痰液样本中总共分离出255株病原菌,其中95株(37.3%)鉴定为多重耐药菌.多重耐药菌中,革兰阴性菌为75株(78.9%),革兰阳性细菌20株(21.1%).19株铜绿假单胞菌对哌拉西林、头孢他啶、头孢吡肟、氨曲南、环丙沙星的耐药率>63%;16株肺炎克雷伯菌对氨苄西林/舒巴坦、头孢唑林、头孢他啶、头孢呋辛、头孢曲松的耐药率>56%;14株鲍氏不动杆菌对氨苄西林、氨苄西林/舒巴坦、头孢吡肟、阿米卡星的耐药率≥50%;11株大肠埃希菌对氨苄西林/舒巴坦、头孢唑林、头孢他啶、头孢呋辛、头孢曲松、氨曲南、左氧氟沙星、复方新诺明的耐药率>54%;7株嗜麦芽窄食单胞菌对头孢唑林、左氧氟沙星的耐药率>57%.7株金黄色葡萄球菌对头孢西丁、青霉素、红霉素、克林霉素、庆大霉素的耐药率>57.0%;4株表皮葡萄球菌对头孢西丁、青霉素、红霉素、克林霉素、庆大霉素、复方新诺明的耐药率≥75%;4株肺炎链球菌对红霉素、克林霉素的耐药率均为100%.结论 肺部感染患者痰液样本中出现多重耐药菌,分析不同细菌对不同抗生素产生不同的耐药性,可为随后肺部感染的控制提供重要参考依据.
Study on drug resistance of multi-drug resistant bacteria in patients with pulmonary infection
Objective To investigate the drug resistance of multi-drug resistant bacteria (MDR) in patients with pulmonary infection. Methods 50 patients with pulmonary infection were selected to undergo pathogen culture and drug susceptibility test. The composition of multi-drug resistant bacteria,drug resistance of gram-negative bacteria and drug resistance of gram-positive bacteria in pulmonary infection were analyzed. Results A total of 255 stains of pathogenic bacteria were isolated from the sputum samples of 50 patients with pulmonary infection,of which 95 strains (37.3%) were identified as multi-drug resistant bacteria. There were 75 strains (78.9%) of Gram-negative bacteria and 20 strains (21.1%) of Gram-positive bacteria in multi-drug resistant bacteria. The drug resistance rate of 19 strains of Pseudomonas aeruginosa to piperacillin,ceftazidme,cefepime,aztreonam and ciprofloxacin was>63%. The drug resistance rate of 16 strains of Klebsiella pneumoniae to ampicillin/sulbactam,cefazolin,ceftazidme,cefuroxime and ceftriaxone was more than 56%. The drug resistance rate of 14 strains of Acinetobacter baui to ampicillin,ampicillin/sulbactam,cefepime and amikacin was ≥50%. The drug resistance rate of 11 E. coli strains to ampicillin/sulbactam,cefazolin,ceftazidme,cefuroxime,ceftriaxone,aztreonam,levofloxacin and cotrimoxazole was>54%. The drug resistance rate of 7 strains of stenotrophomonas maltophilia to cefazolin and levofloxacin was>57%. The drug resistance rate of 7 strains of Staphylococcus aureus to cefoxitin,penicillin,erythromycin,clindamycin,and gentamicin was>57.0%. The drug resistance rate of 4 strains of Staphylococcus epidermidis to cefoxitin,penicillin,erythromycin,clindamycin,gentamicin and cotrimoxazole was ≥75%. The drug resistance rate of 4 strains of Streptococcus pneumoniae to erythromycin and clindamycin was 100%. Conclusion Multi-drug resistant bacteria has been found in sputum samples of patients with pulmonary infection,and analysis of the resistance of different bacteria to different antibiotics can provide an important reference for the subsequent control of pulmonary infection.

Pulmonary infectionMulti-drug resistant bacteriaDrug resistanceGram-negative bacteriaGram-positive bacteriaDrug sensitivity test

崔国华

展开 >

226241 启东市第二人民医院内科、重症医学科

肺部感染 多重耐药菌 耐药性 革兰阴性菌 革兰阳性菌 药敏试验

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(21)